Summit, N.J. – – September 11, 2026 -- A new over-the-counter pain reliever combining acetaminophen and naproxen sodium in a single pill has cleared two Phase 3 clinical trials, with data presented this week at the 20th Annual PAINWeek Conference in Las Vegas, running September 8-11, 2026.